This report contains market size and forecasts of Non-Invasive Prenatal Screening (NIPS) in Global, including the following market information:
Global Non-Invasive Prenatal Screening (NIPS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Invasive Prenatal Screening (NIPS) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trisomy 21 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Prenatal Screening (NIPS) include Myriad Genetics, Illumina, Progenity, Natera, Yourgene Health, Roche Sequencing Solutions (RSS), Eurofins LifeCodexx GmbH, Labcorp and PerkinElmer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Prenatal Screening (NIPS) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Prenatal Screening (NIPS) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Prenatal Screening (NIPS) Market Segment Percentages, by Type, 2021 (%)
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Global Non-Invasive Prenatal Screening (NIPS) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Prenatal Screening (NIPS) Market Segment Percentages, by Application, 2021 (%)
Clinical Laboratories
Hospital
Global Non-Invasive Prenatal Screening (NIPS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Non-Invasive Prenatal Screening (NIPS) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Prenatal Screening (NIPS) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Invasive Prenatal Screening (NIPS) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony